Match tier
Listed
Presence
Current · Arkansas
Last published
2021
Sources
OpenAlex · ORCID
Refreshed
2026-10-05
L
L.P.F. Balapiti-Modarage
Role not yet determined Is this you? Add your title
2 h-index
5 pubs
201 cited
Research Areas
Biomedical Subjects
Links
Biography and Research Information
OverviewAI-generated summary
L.P.F. Balapiti-Modarage studies the structural basis of enzyme inhibition, with recent work focusing on SARS-CoV-2 Nsp3 macrodomain targeting. This research leverages insights from human poly(ADP-ribose) glycohydrolase (PARG) structures and inhibitors. Balapiti-Modarage has authored 5 publications with 189 citations and an h-index of 2. Key collaborators include Shobanbabu Bommagani and Darin E. Jones, both from the University of Arkansas for Medical Sciences, with whom Balapiti-Modarage shares one publication each. The researcher's work is situated within the broader fields of molecular biology and pharmacology, contributing to the understanding of enzyme function and potential therapeutic targets.
Metrics
- h-index: 2
- Publications: 5
- Citations: 201
Selected Publications
-
Targeting SARS-CoV-2 Nsp3 macrodomain structure with insights from human poly(ADP-ribose) glycohydrolase (PARG) structures with inhibitors (2021)
-
Selective small molecule PARG inhibitor causes replication fork stalling and cancer cell death (2019)
Collaboration Network
Top Collaborators
Jerry H. Houl
The University of Texas MD Anderson Cancer Center (US)
2 shared publications
- Selective small molecule PARG inhibitor causes replication fork stalling and cancer cell death
- Targeting SARS-CoV-2 Nsp3 macrodomain structure with insights from human poly(ADP-ribose) glycohydrolase (PARG) structures with inhibitors
Chris A. Brosey
The University of Texas MD Anderson Cancer Center (US)
2 shared publications
- Selective small molecule PARG inhibitor causes replication fork stalling and cancer cell death
- Targeting SARS-CoV-2 Nsp3 macrodomain structure with insights from human poly(ADP-ribose) glycohydrolase (PARG) structures with inhibitors
Albino Bacolla
The University of Texas MD Anderson Cancer Center (US)
2 shared publications
- Selective small molecule PARG inhibitor causes replication fork stalling and cancer cell death
- Targeting SARS-CoV-2 Nsp3 macrodomain structure with insights from human poly(ADP-ribose) glycohydrolase (PARG) structures with inhibitors
L.S. Warden
The University of Texas MD Anderson Cancer Center (US)
2 shared publications
- Selective small molecule PARG inhibitor causes replication fork stalling and cancer cell death
- Targeting SARS-CoV-2 Nsp3 macrodomain structure with insights from human poly(ADP-ribose) glycohydrolase (PARG) structures with inhibitors
Davide Moiani
The University of Texas MD Anderson Cancer Center (US)
2 shared publications
- Selective small molecule PARG inhibitor causes replication fork stalling and cancer cell death
- Targeting SARS-CoV-2 Nsp3 macrodomain structure with insights from human poly(ADP-ribose) glycohydrolase (PARG) structures with inhibitors
Darin E. Jones
University of Arkansas for Medical Sciences
2 shared publications
In database
- Selective small molecule PARG inhibitor causes replication fork stalling and cancer cell death
- Targeting SARS-CoV-2 Nsp3 macrodomain structure with insights from human poly(ADP-ribose) glycohydrolase (PARG) structures with inhibitors
Zamal Ahmed
The University of Texas MD Anderson Cancer Center (US)
2 shared publications
- Selective small molecule PARG inhibitor causes replication fork stalling and cancer cell death
- Targeting SARS-CoV-2 Nsp3 macrodomain structure with insights from human poly(ADP-ribose) glycohydrolase (PARG) structures with inhibitors
John A. Tainer
The University of Texas MD Anderson Cancer Center (US)
2 shared publications
- Selective small molecule PARG inhibitor causes replication fork stalling and cancer cell death
- Targeting SARS-CoV-2 Nsp3 macrodomain structure with insights from human poly(ADP-ribose) glycohydrolase (PARG) structures with inhibitors
Zu Ye
The University of Texas MD Anderson Cancer Center (US)
1 shared publication
- Selective small molecule PARG inhibitor causes replication fork stalling and cancer cell death
Sarita Namjoshi
The University of Texas MD Anderson Cancer Center (US)
1 shared publication
- Selective small molecule PARG inhibitor causes replication fork stalling and cancer cell death
Daniel J. Laverty
Harvard University (US)
1 shared publication
- Selective small molecule PARG inhibitor causes replication fork stalling and cancer cell death
Brian L. Walker
University of Arkansas at Little Rock
1 shared publication
In database
- Selective small molecule PARG inhibitor causes replication fork stalling and cancer cell death
Yasin Pourfarjam
University of Cincinnati (US)
1 shared publication
- Selective small molecule PARG inhibitor causes replication fork stalling and cancer cell death
Naga Babu Chinnam
The University of Texas MD Anderson Cancer Center (US)
1 shared publication
- Selective small molecule PARG inhibitor causes replication fork stalling and cancer cell death
Roderick A. Stegeman
Washington University in St. Louis (US)
1 shared publication
- Selective small molecule PARG inhibitor causes replication fork stalling and cancer cell death
Similar Researchers
Based on overlapping research topics
Reid Shelton
University of Arkansas at Fayetteville
Protein Structure and Dynamics
Molecular Biology Techniques and Applications
Disease Mechanisms Research
Emma Lauret
University of Arkansas at Fayetteville
Protein Structure and Dynamics
Molecular Biology Techniques and Applications
Disease Mechanisms Research
Ann Varghese
National Center for Toxicological Research
Protein Structure and Dynamics
SARS-CoV-2 and COVID-19 Research
Molecular Biology Techniques and Applications
Maryanna Wells McClure
University of Arkansas at Fayetteville
Protein Structure and Dynamics
Molecular Biology Techniques and Applications
Disease Mechanisms Research
Dylan S. Ogden
University of Arkansas at Fayetteville
Protein Structure and Dynamics
SARS-CoV-2 and COVID-19 Research
Molecular Biology Techniques and Applications
Haarika Ayyadevara
University of Arkansas at Fayetteville
Protein Structure and Dynamics
Drug Discovery and Development
Molecular Biology Techniques and Applications